Uric acid for stroke: glimmer of hope or false dawn?

Affiliations

¹ Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville 3010, VIC, Australia; Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville 3010, VIC, Australia.
² Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville 3010, VIC, Australia.
³ Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville 3010, VIC, Australia. Electronic address: gdonnan@unimelb.edu.au.

Comment

Bruce C V Campbell et al. Lancet Neurol. 2014 May.

. 2014 May;13(5):440-1.

doi: 10.1016/S1474-4422(14)70019-5. Epub 2014 Apr 2.

¹ Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville 3010, VIC, Australia; Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville 3010, VIC, Australia.
² Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville 3010, VIC, Australia.
³ Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville 3010, VIC, Australia. Electronic address: gdonnan@unimelb.edu.au.

No abstract available

Comment on

Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial.
Chamorro A, Amaro S, Castellanos M, Segura T, Arenillas J, Martí-Fábregas J, Gállego J, Krupinski J, Gomis M, Cánovas D, Carné X, Deulofeu R, Román LS, Oleaga L, Torres F, Planas AM; URICO-ICTUS Investigators. Chamorro A, et al. Lancet Neurol. 2014 May;13(5):453-60. doi: 10.1016/S1474-4422(14)70054-7. Epub 2014 Apr 2. Lancet Neurol. 2014. PMID: 24703208 Clinical Trial.